Proactive Investors USA & CanadaMannKind Corp. (MNKD) Leaped To A 3-Month High On FDA RecommendationRTT NewsMannKind Corp. (MNKD: Quote) announced after the bell Tuesday that the Endocrinologic and Metabolic Drugs Advisory Committee of the FDA voted 13 to 1 to recommend that AFREZZA Inhalation Powder be granted marketing approval. MannKind gapped …FDA advisers give thumbs up to MannKind’s inhaled insulin drug for diabeticsTech TimesMannKind Corporation: Saved by FDA?Guardian Liberty VoiceMannkind’s inhaled insulin clears big hurdleDanbury News TimesSan Fernando Valley Business Journal -Reuters -Huffington Postall 159 news articles …Read Full Story
MannKind Corp. (MNKD) Leaped To A 3-Month High On FDA Recommendation - RTT News
Real Estate of Cebu
